Pharmacological evaluation of anti-inflammatory pyrrole-acetic acid derivative eye drops

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 4, 1997, Pages 353-361

  Bucolo, Claudio ^a   Spadaro, Angelo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; PYRROLE DERIVATIVE; TOLMETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG BIOAVAILABILITY; DRUG EFFECT; EYE INFLAMMATION; FEMALE; NONHUMAN; RABBIT; TOPICAL DRUG ADMINISTRATION;

EID: 0030798667     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.353     Document Type: Article

References (17)

1. Wong, S., Gardocki, F. and Pruss, T.P. Pharmacologic evaluation of Tolectin (Tolmetin, McN-2559) and McN-2891, two anti-inflammatory agents. J. Pharmacol. Exp. Ther., 141:127-138, 1973.
2. Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs, 15:429-450, 1978.
3. Gilbert, D. and Horlington, M. Effects of a topically applied non-steroidal anti-inflammatory drug, tolmetin, on experimentally induced uveitis in the rabbit. Proc. Int. Soc. Eye Res., 2:105, 1982.
4. Dunne, J.A., Jacobs, N., Morrison, A. and Gilbert, D.J. Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br. J. Ophthalmol., 69:120-125, 1985.
5. Young, B.J., Cunningham, W.F. and Akingbehin, T. Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis. Br. J. Ophthalmol., 66:389-391, 1982.
6. Spampinato, S., Marino, A., Bucolo, C., Canossa, M., Bachetti, T. and Mangiafico, S. Effects of sodium naproxen on rabbit ocular inflammation induced by sodium arachidonate. J. Ocular Pharmacol., 7:125-133, 1991.
7. McDonald, T.O. and Shadduck, J.A. Eye irritation. In Advances in Modern Toxicology, Vol. 4, Marzulli, F.M. and Maibach, H.I., eds., John Wiley and Sons, New York, 1977, p. 139-191.
8. Fleisher, L.N. and McGahan, M.C. Time course for prostaglandin synthesis by rabbit lens during endotoxin-induced ocular inflammation. Curr. Eye Res., 5:629-634, 1986.
9. Stjernschantz, J. Autacoids and neuropeptides. In Pharmacology of the Eye, Sears, L., ed., Springer-Verlag, Berlin, 1984, p. 311-365.
10. Kenyon, K.R., Berman, M., Rose, J. and Gage, J. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Evidence for the role of polymorphonuclear leukocytes in collagen degradation. Invest. Ophthalmol. Vis. Sci., 18:570-587, 1979.
11. Masuda, K. Anti-inflammatory agents: nonsteroidal anti-inflammatory drugs. In Pharmacology of the Eye, Sears, L., ed., Springer-Verlag, Berlin, 1984, p. 539-551.
12. Samiy, N. and Foster, C.S. The role of nonsteroidal anti-inflammatory drugs in ocular inflammation. Int. Ophthalmol. Clin., 36:195-206, 1996.
13. Abelson, M.B., Butrus, S.I., Gilbert, H.K., Larson, D.L., Corey, E.J. and Smith, L.M. Topical arachidonic acid: a model for screening anti-inflammatory agents. J. Ocular Pharmacol., 3:63-75, 1987.
14. Bazan, H.E P., Tao, Y. and Hurst J.S. Platelet-activating factor antagonists and ocular inflammation. J. Ocular Pharmacol., 10:319-327, 1994.
15. Hurst, J.S. and Bazan, H.E.P. The platelet-activating factor precursor of the injured cornea is selectively implicated in arachidonate and eicosanoid release. Curr. Eye Res., 12:655-663, 1993.
16. Hurst, J.S. and Bazan, H.E.P. Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists. J. Ocular Pharmacol., 11:329-337, 1995.
17. Bazan, N.G., Fletcher, B.S., Herschman, H.R. and Mukherjee, P.K. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc. Natl. Acad. Sci. USA, 91:5252-5256, 1994.